title: Kinetic parameters and plasma zinc concentration correlate well with net loss and gain of zinc from men.
abstract: The search for a reliable, convenient indicator of Zn status was the focus of research for several decades. Plasma Zn concentration is still the most widely used clinical measurement, despite the known problems of interpretation. More recently, researchers suggested that isotopically determined kinetic parameters, such as the exchangeable Zn pool (EZP), may more accurately and reliably reflect body Zn status. The objective of this study was to examine the relationship between net body Zn loss and gain during acute changes in dietary Zn intake with biochemical and kinetic indices of Zn status. Five men participated in an 85-d Zn depletion/repletion study. Net body Zn loss and gain were determined from the difference between dietary plus intravenously administered Zn and Zn excretion. Biochemical indicators of Zn status included plasma Zn, plasma alkaline phosphatase activity, and plasma retinol binding protein concentration. Following intravenous administration of (70)Zn or (67)Zn, a compartmental model was used to determine EZP mass, fractional Zn absorption, endogenous zinc excretion (EZE), and plasma Zn flux. The changes in total body zinc correlated best with changes in plasma Zn (r(2) = 0.826, P < 0.001), EZE (r(2) = 0.773, P < 0.001), and plasma Zn flux (r(2) = 0.766, P < 0.001). This study confirms that plasma Zn concentration is a valid indicator of whole-body Zn status in the absence of confounding factors; however, further research is needed to determine how kinetic parameters respond to conditions where plasma Zn concentration is known to be unreliable.
authors.affiliation: Department of Biological Sciences, University of Central Lancashire, Preston PR1 2HE, UK.
authors.forename: Nicola M
authors.initials: NM
authors.lastname: Lowe
authors.forename: Leslie R
authors.initials: LR
authors.lastname: Woodhouse
authors.forename: Barbara
authors.initials: B
authors.lastname: Sutherland
authors.forename: David M
authors.initials: DM
authors.lastname: Shames
authors.forename: Betty J
authors.initials: BJ
authors.lastname: Burri
authors.forename: Steven A
authors.initials: SA
authors.lastname: Abrams
authors.forename: Judith R
authors.initials: JR
authors.lastname: Turnlund
authors.forename: Malcolm J
authors.initials: MJ
authors.lastname: Jackson
authors.forename: Janet C
authors.initials: JC
authors.lastname: King
mesh_terms: D000042:Absorption; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D004032:Diet; D006801:Humans; D007275:Injections, Intravenous; D007700:Kinetics; D008297:Male; D009994:Osmolar Concentration; D012177:Retinol-Binding Proteins / Q000378:metabolism; D054839:Retinol-Binding Proteins, Plasma; D015032:Zinc / Q000008:administration & dosage / Q000097:blood* / Q000172:deficiency* / Q000652:urine; D015033:Zinc Isotopes
chemical_list: D012177:Retinol-Binding Proteins; D054839:Retinol-Binding Proteins, Plasma; D015033:Zinc Isotopes; D000469:Alkaline Phosphatase; D015032:Zinc